Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Work In Process (2016 - 2022)

Usana Health Sciences (USNA) has disclosed Work In Process for 12 consecutive years, with $8.0 million as the latest value for Q3 2022.

  • Quarterly Work In Process fell 7.44% to $8.0 million in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $8.0 million through Jul 2022, down 7.44% year-over-year, with the annual reading at $9.6 million for FY2022, 3.72% down from the prior year.
  • Work In Process for Q3 2022 was $8.0 million at Usana Health Sciences, down from $9.7 million in the prior quarter.
  • The five-year high for Work In Process was $14.5 million in Q4 2018, with the low at $8.0 million in Q3 2022.
  • Average Work In Process over 5 years is $10.7 million, with a median of $10.0 million recorded in 2018.
  • The sharpest move saw Work In Process surged 71.2% in 2018, then tumbled 39.12% in 2020.
  • Over 5 years, Work In Process stood at $14.5 million in 2018, then fell by 16.39% to $12.1 million in 2019, then decreased by 29.85% to $8.5 million in 2020, then grew by 22.14% to $10.4 million in 2021, then dropped by 23.0% to $8.0 million in 2022.
  • According to Business Quant data, Work In Process over the past three periods came in at $8.0 million, $9.7 million, and $9.6 million for Q3 2022, Q2 2022, and Q1 2022 respectively.